---
title: "Karyopharm Therapeutics drops 14% in premarket on Nasdaq delisting notice"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304981768.md"
description: "Karyopharm Therapeutics fell nearly 14% to $0.0346 in premarket after Nasdaq notified it of delisting effective Nov. 11."
datetime: "2026-11-10T09:00:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304981768.md)
  - [en](https://longbridge.com/en/news/304981768.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304981768.md)
generator: "portal-rs"
---

# Karyopharm Therapeutics drops 14% in premarket on Nasdaq delisting notice

Karyopharm Therapeutics (KPTI.US) fell nearly **14%** in premarket trading to a record low of **$0.0346**.

Nasdaq notified the company that it will be delisted, with trading suspended on Nov. 11.

Karyopharm Therapeutics filed for Chapter 11 bankruptcy protection on Nov. 2, 2026, under which existing equity is expected to be canceled. The company is seeking a **$110 million** debtor-in-possession financing facility and announced a planned merger with Ayrmid Ltd. as part of its restructuring. The transaction includes up to **$55 million** in DIP financing and is expected to close in the first quarter of 2027.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [KPTIQ.US](https://longbridge.com/en/quote/KPTIQ.US.md)

## Related News & Research

- [BUZZ-Karyopharm tumbles after bankruptcy filing, merger plan with Ayrmid](https://longbridge.com/en/news/303968036.md)
- [Karyopharm reports sustained benefit through 48 weeks in Phase 3 selinexor myelofibrosis trial](https://longbridge.com/en/news/304290863.md)
- [Karyopharm extends noteholder forbearance period to Oct. 22](https://longbridge.com/en/news/301835273.md)
- [Is the Stock Market Going to Crash? Warren Buffett's Warning Is Hard to Ignore.](https://longbridge.com/en/news/305154637.md)
- [14 companies sold 108,247 Bitcoin in 2026, but here’s why it’s not what it looks like!](https://longbridge.com/en/news/305139945.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**